Wikisage, the free encyclopedia of the second generation, is digital heritage
Brivaracetam: Difference between revisions
Jump to navigation
Jump to search
(init) |
m (wData) |
||
Line 1: | Line 1: | ||
<gallery>File:Brivaracetam3d.png|(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide</gallery> | <gallery>File:Brivaracetam3d.png|(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide</gallery> | ||
4n propyl analog of [[levetiracetam]] | 4n propyl analog of [[levetiracetam]], this a levetiracetam may have potential in the mangement of progressive myoclonic [[epilepsy|epilepsies]] | ||
<ref>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/pdf/ndt-11-2967.pdf</ref> | |||
<references/> |
Revision as of 01:17, 30 March 2016
-
(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide
4n propyl analog of levetiracetam, this a levetiracetam may have potential in the mangement of progressive myoclonic epilepsies [1]